Beclin, a novel bcl-2 interacting gene near BRCA1 on chromosome 17q21 and methods of use
AssigneeThe Trustees of Columbia University in the City of New York
InventorBeth Cindy Levine
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Trustees of Columbia University in the City of New York
InventorBeth Cindy Levine
Estimating the term…
This invention provides for an isolated nucleic acid which encodes a wildtype human Beclin and a mutant human Beclin. This invention also provides a vector containing the isolated nucleic acid which encodes a wildtype human Beclin. This invention also provides for a method of producing a wildtype human Beclin. This invention also provides for a purified, wildtype human Beclin. This invention also provides for a method for determining whether a subject has a predisposition for cancer. This invention also provides a method for determining whether a subject has cancer. This invention also provides for a method for inhibiting cell proliferation in cells unable to regulate themselves. This invention also provides for a method for treating a subject who has cancer. This invention also provides a pharmaceutical composition composed of the wildtype human Beclin. This invention also provides a method for detecting a mutant human Beclin in a subject. This invention also provides a method for treating a subject unable to control apoptosis in the cells of the subject.
A method for identifying a subject with a predisposition for cancer, comprising:
A method of detecting a nucleic acid encoding a mutant human beclin comprising:
A method of detecting a nucleic acid encoding a mutant human beclin comprising:
Dependencies are inferred from the claim text.